
Craig D. Ricci
Examiner (ID: 11352, Phone: (571)270-5864 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1611, 1628, 1614 |
| Total Applications | 1565 |
| Issued Applications | 763 |
| Pending Applications | 148 |
| Abandoned Applications | 690 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13774647
[patent_doc_number] => 20190000862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => METHODS AND SYSTEMS FOR THE DELIVERY OF A THERAPEUTIC AGENT
[patent_app_type] => utility
[patent_app_number] => 16/041168
[patent_app_country] => US
[patent_app_date] => 2018-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16041168
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/041168 | METHODS AND SYSTEMS FOR THE DELIVERY OF A THERAPEUTIC AGENT | Jul 19, 2018 | Abandoned |
Array
(
[id] => 15895261
[patent_doc_number] => 20200147149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-14
[patent_title] => COMPOSITIONS AND METHODS FOR THE MODULATION OF GUT SENSORY CELLS
[patent_app_type] => utility
[patent_app_number] => 16/632062
[patent_app_country] => US
[patent_app_date] => 2018-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16632062
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/632062 | COMPOSITIONS AND METHODS FOR THE MODULATION OF GUT SENSORY CELLS | Jul 16, 2018 | Abandoned |
Array
(
[id] => 16175392
[patent_doc_number] => 20200222360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => STABLE CANNABINOID COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/628856
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4508
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628856
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/628856 | STABLE CANNABINOID COMPOSITIONS | Jul 5, 2018 | Abandoned |
Array
(
[id] => 13774429
[patent_doc_number] => 20190000753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => NASAL DOSAGE FORMS OF DIHYDROERGOTAMINE
[patent_app_type] => utility
[patent_app_number] => 16/025629
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025629 | NASAL DOSAGE FORMS OF DIHYDROERGOTAMINE | Jul 1, 2018 | Abandoned |
Array
(
[id] => 15320831
[patent_doc_number] => 20200000745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => Chemical medicinal composition used for the improvement of sleep
[patent_app_type] => utility
[patent_app_number] => 15/972192
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 117
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15972192
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/972192 | Chemical medicinal composition used for the improvement of sleep | Jul 1, 2018 | Abandoned |
Array
(
[id] => 13504455
[patent_doc_number] => 20180303770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => TREATMENT OF METHYLMALONIC ACIDURIA, ISOVALERIC ACIDURIA, AND OTHER ORGANIC ACIDURIAS WITH TOCOTRIENOL QUINONES
[patent_app_type] => utility
[patent_app_number] => 16/019363
[patent_app_country] => US
[patent_app_date] => 2018-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16019363
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/019363 | TREATMENT OF METHYLMALONIC ACIDURIA, ISOVALERIC ACIDURIA, AND OTHER ORGANIC ACIDURIAS WITH TOCOTRIENOL QUINONES | Jun 25, 2018 | Abandoned |
Array
(
[id] => 13490099
[patent_doc_number] => 20180296592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Effervescent Dosage Form
[patent_app_type] => utility
[patent_app_number] => 16/015224
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16015224
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/015224 | Effervescent dosage form | Jun 21, 2018 | Issued |
Array
(
[id] => 14210739
[patent_doc_number] => 20190117754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 16/016473
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16016473
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/016473 | Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides | Jun 21, 2018 | Issued |
Array
(
[id] => 13489925
[patent_doc_number] => 20180296505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => BOOSTER DRUG THERAPY FOR MYCOBACTERIUM INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/015415
[patent_app_country] => US
[patent_app_date] => 2018-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16015415
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/015415 | BOOSTER DRUG THERAPY FOR MYCOBACTERIUM INFECTIONS | Jun 21, 2018 | Abandoned |
Array
(
[id] => 13489919
[patent_doc_number] => 20180296502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Method for Enhancing Folding and Transport of Misfolded Glucocerebrosidase
[patent_app_type] => utility
[patent_app_number] => 16/014739
[patent_app_country] => US
[patent_app_date] => 2018-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16014739
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/014739 | Method for enhancing folding and transport of misfolded glucocerebrosidase | Jun 20, 2018 | Issued |
Array
(
[id] => 17966998
[patent_doc_number] => 11484502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Pharmaceutical composition comprising PDE9 inhibitor
[patent_app_type] => utility
[patent_app_number] => 16/609514
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16606
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609514
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609514 | Pharmaceutical composition comprising PDE9 inhibitor | May 29, 2018 | Issued |
Array
(
[id] => 17769311
[patent_doc_number] => 11401236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Resorcinol derivatives for their cosmetic use
[patent_app_type] => utility
[patent_app_number] => 16/615936
[patent_app_country] => US
[patent_app_date] => 2018-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12858
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16615936
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/615936 | Resorcinol derivatives for their cosmetic use | May 29, 2018 | Issued |
Array
(
[id] => 15740423
[patent_doc_number] => 20200109099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => POLYPHENYLMETHANOL SURFACTANTS
[patent_app_type] => utility
[patent_app_number] => 16/611714
[patent_app_country] => US
[patent_app_date] => 2018-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16611714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/611714 | POLYPHENYLMETHANOL SURFACTANTS | May 28, 2018 | Abandoned |
Array
(
[id] => 13440587
[patent_doc_number] => 20180271836
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => TOPICAL NON-AQUEOUS PHARMACEUTICAL FORMULATIONS CONTAINING AN ALKYL SULFOXIDE FOR THE TREATMENT OF TOPICAL REFERENCE INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 15/990727
[patent_app_country] => US
[patent_app_date] => 2018-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990727
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/990727 | TOPICAL NON-AQUEOUS PHARMACEUTICAL FORMULATIONS CONTAINING AN ALKYL SULFOXIDE FOR THE TREATMENT OF TOPICAL REFERENCE INFECTIONS | May 27, 2018 | Abandoned |
Array
(
[id] => 15990593
[patent_doc_number] => 20200171167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => CATIONIC NUCLEIC ACID SCAVENGER AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/618281
[patent_app_country] => US
[patent_app_date] => 2018-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5369
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16618281
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/618281 | CATIONIC NUCLEIC ACID SCAVENGER AND USES THEREOF | May 23, 2018 | Abandoned |
Array
(
[id] => 15553351
[patent_doc_number] => 20200061087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => Inhibiting the Fungal Cell-Surface Phospate Transporter PHO84
[patent_app_type] => utility
[patent_app_number] => 16/480828
[patent_app_country] => US
[patent_app_date] => 2018-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18252
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480828
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480828 | Inhibiting the Fungal Cell-Surface Phospate Transporter PHO84 | May 15, 2018 | Abandoned |
Array
(
[id] => 17127344
[patent_doc_number] => 20210302113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-30
[patent_title] => FLUORINATED DIAMINOOLEFINS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/496010
[patent_app_country] => US
[patent_app_date] => 2018-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9800
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496010
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/496010 | FLUORINATED DIAMINOOLEFINS AND METHODS OF USING THE SAME | May 14, 2018 | Abandoned |
Array
(
[id] => 13492861
[patent_doc_number] => 20180297973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-18
[patent_title] => Nitroalkene Trolox Derivatives and Methods of Use Thereof In The Treatment And Prevention of Inflammation Related Conditions
[patent_app_type] => utility
[patent_app_number] => 15/972518
[patent_app_country] => US
[patent_app_date] => 2018-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15972518
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/972518 | Nitroalkene Trolox Derivatives and Methods of Use Thereof In The Treatment And Prevention of Inflammation Related Conditions | May 6, 2018 | Abandoned |
Array
(
[id] => 14991143
[patent_doc_number] => 20190314529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => DYE ENHANCED VISUALIZATION OF CATARACT SURGERY
[patent_app_type] => utility
[patent_app_number] => 15/953310
[patent_app_country] => US
[patent_app_date] => 2018-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6473
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15953310
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/953310 | Dye enhanced visualization of cataract surgery | Apr 12, 2018 | Issued |
Array
(
[id] => 13328351
[patent_doc_number] => 20180215713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-02
[patent_title] => AMINOBENZAMIDE DERIVATIVES AS USEFUL AGENTS FOR CONTROLLING ANIMAL PARASITES
[patent_app_type] => utility
[patent_app_number] => 15/938900
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938900
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/938900 | Aminobenzamide derivatives as useful agents for controlling animal parasites | Mar 27, 2018 | Issued |